Evidence-based Text Messages to Target Diet and Physical Activity
Launched by UNIVERSITY OF MANCHESTER · Nov 30, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is looking to create helpful text messages to support people with type 2 diabetes in making better choices about their diet and physical activity. The goal is to develop messages that encourage positive changes in these areas, which can be very important for managing diabetes effectively. The trial is currently recruiting participants, including both experts in behavior change and individuals with type 2 diabetes.
To be eligible for the study, participants should be at least 18 years old, have a diagnosis of type 2 diabetes, and have access to a mobile phone they can use to send and receive messages. Participants will help by sharing their experiences and providing feedback on the text messages created. It's important to note that certain individuals, such as those who have recently been hospitalized for diabetes-related issues or are pregnant, will not be eligible to participate. Overall, this trial aims to find new ways to support people living with diabetes through everyday technology.
Gender
ALL
Eligibility criteria
- • For the expert workshop -
- • Inclusion criteria: researchers with expertise in behaviour change, physical activity, diet and/or diabetes
- • - For focus group
- • Inclusion criteria
- • Participant is willing and able to give informed consent for participation in the study.
- • Male or female, aged 18 years or above.
- • A diagnosis of type 2 diabetes.
- • Has access to a mobile-phone (shared access is allowed with permission of phone owner)
- • Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages or messaging within smartphone applications).
- • Exclusion criteria
- • Moved out of England prior to taking part in the study
- • For the anticipated acceptability survey and experienced acceptability study
- • Inclusion criteria
- • Participant is willing and able to give informed consent for participation in the study.
- • Aged 18 years or above.
- • A diagnosis of type 2 diabetes.
- • Has access to a mobile-phone (shared access is allowed with permission of phone owner)
- • Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages).
- • Exclusion criteria
- • Within three months of a hospital admission for hyperglycaemia or hypoglycaemia.
- • Pregnant or within three months post-partum by self-report
- • Underweight (For anticipated acceptability this will be by self-report, for experienced acceptability BMI\<18.5)
- • Historical or current diagnosis of an eating disorder Prescribed insulin for their diabetes
Trial Officials
Kiera Bartlett, PhD
Principal Investigator
University of Manchester
About University Of Manchester
The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, , United Kingdom
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials